Knee replacement surgery helps relieve pain and restore function in severely diseased knee joints. The procedure involves cutting away damaged bone and cartilage from your thighbone, shinbone, and kneecap, and replacing it with an artificial joint (prosthesis) made of metal alloys, high-grade plastics, and polymers. The demand for this surgery is expected to increase over the forecast period, owing to the increasing prevalence of types of arthritis such as osteoarthritis, psoriatic arthritis, and rheumatoid arthritis, and increasing geriatric population. For instance, according to a study published in the Journal of Bone and Joint Surgery American (JBJSA) in 2015, more than 7% of people in their 70s and 10% of people in their 80s have had a knee replacement. Also, rising technological advancements such as minimally invasive surgeries along with presence of better implant materials are likely to drive growth of the knee replacement market.
Knee Replacement Market – Impact of Coronavirus (COVID-19) Pandemic
During the COVID-19 pandemic, many patients with arthritis are struggling to receive treatment due to hospitals canceling or delaying surgeries and other procedures, including arthroplasty and other knee replacement surgeries. There is also concern that patients who have mild arthritis that require timely implementation of surgery have unfortunately concluded that the risk of contracting COVID-19 may outweigh the benefits of arthroplasty. As non-essential surgery restrictions remain in parts of the U.S., the COVID-19 pandemic is having a profound impact on hip and knee arthroplasty surgery volume and could translate to major financial loss according to a study by University of Iowa, U.S. According to the same study, researchers estimated that 30,000 primary and 3,000 revision total hip arthroplasty and total knee arthroplasty procedures will be canceled every week while restrictions remain in place.
The global knee replacement market is estimated to be valued at US$ 9.4 billion in 2020 and is expected to exhibit a CAGR of 4.1% during the forecast period (2020-2027).
Figure 1. Global Knee Replacement Market Share (%), By Region, 2027
Increasing product approvals and launches, and prevalence of arthritis are expected to drive growth of the global knee replacement market
Major factors driving the market growth include the rising focus of established players in gaining product approvals and launching new products, and expanding their consumer base by offering innovative and technologically advanced products. For instance, in October 2019, IMPLANET, a medical technology company specializing in vertebral and knee-surgery implants, announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the cemented version of its Madison total knee prosthesis. This is the first step towards targeted clearance of complete total knee replacement (TKR) range.
Furthermore, increasing prevalence of types of arthritis is expected to boost the global knee replacement market growth in the near future. For instance, according to the data of National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), around 23% of all adults or more than 54 million people aged 18 years or older have arthritis in the U.S., as of 2019. As per the same source, it is a leading cause of work disability, with annual costs for medical care and lost earnings of US$ 303.5 billion. The prevalence of osteoarthritis is increasing due to population ageing and an increase in related factors such as obesity and sedentary life style. The physical disability arising from pain and loss of functional capacity reduces quality of life and increases the risk of further morbidity. As highly effective medicinal management is not available, emphasis should be given to preventive aspect of life style measures in the form of healthy diet and exercise.
|Base Year:||2019||Market Size in 2020:||US$ 9.4 Bn|
|Historical Data for:||2017 to 2019||Forecast Period:||2020 to 2027|
|Forecast Period 2020 to 2027 CAGR:||4.1%||2027 Value Projection:||US$ 12.9 Bn|
Zimmer Biomet, Stryker Corporation, Smith & Nephew Plc, Johnson & Johnson Services Inc., B. Braun Melsungen AG, Medacta International, MicroPort Scientific Corporation, ConforMIS, Inc., Corin Group, Exactech, Inc., DJO Global, Inc., Baumer Holding AG, SurgTech Inc., Wright Medical Group N.V., and X.NOV
|Restraints & Challenges:||
Knee Replacement Market – Restraints
The major restraining factor of knee replacement market is the increasing number of FDA recalls of knee replacement implants due to product failures, component inconsistency or compromised sterility issues, which may hamper growth of the knee replacement market size over the forecast period. For instance, in July 2020, Zimmer Biomet issued a recall for an unspecified number of polyethylene orthopedic implants for knees, hips, and extremities manufactured between December 2016 and January 2017 in Europe due to the possible presence of elevated endotoxin levels. Expected health consequences include adverse local tissue reaction; critical pain or ache and severe, systemic reaction to allergen or toxin, according to the recall notice.
Knee Replacement Market – Regional Analysis
On the basis of region, the global knee replacement market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to be the most lucrative region in the knee replacement market during the forecast period. The increasing number of product approvals and launches are major factors propelling growth of the North America knee replacement market. For instance, in November 2019, THINK Surgical and MCRA announced that they obtained the U.S. FDA approval for Total Knee Replacement Technology to market the TSolution One Total Knee Application for use in total knee arthroplasty (TKA) in the U.S. The TSolution One Total Knee Application includes CT-based 3D pre-surgical planning software, which allows surgeons to design and prepare, in a virtual environment, the patient’s unique knee joint replacement plan using a choice of knee implant options.
Moreover, Asia Pacific knee replacement market is expected to witness significant growth during the forecast period, owing to increasing prevalence of arthritis in Asia Pacific. For instance, according to a study called ‘Epidemiology of Knee Osteoarthritis in India and Related Factors’, osteoarthritis (OA) is the second most common rheumatologic problem and it is the most frequent joint disease with a prevalence of 22% to 39% in India. OA is more common in women than men. Nearly 45% of women over the age of 65 years have symptoms while 70% of those over 65 years show radiological evidence of OA.
Figure 2. Global Knee Replacement Market Value (US$ Bn) & Y-o-Y Growth (%), 2016-2027
Global Knee Replacement Market - Competitive Landscape
Key players operating in the global knee replacement market include Zimmer Biomet, Stryker Corporation, Smith & Nephew Plc, Johnson & Johnson Services Inc., B. Braun Melsungen AG, Medacta International, MicroPort Scientific Corporation, ConforMIS, Inc., Corin Group, Exactech, Inc., DJO Global, Inc., Baumer Holding AG, SurgTech Inc. Wright Medical Group N.V., and X.NOV.
Knee replacement, also called knee arthroplasty or total knee replacement, is a surgical procedure to resurface a knee damaged by arthritis. Metal and plastic parts are used to cap the ends of the bones that form the knee joint, along with the kneecap. This surgery may be considered for someone who has severe arthritis or a severe knee injury. The goal of knee replacement surgery is to resurface the parts of the knee joint that have been damaged and to relieve knee pain that cannot be controlled by other treatments.
Various types of arthritis may affect the knee joint. Osteoarthritis, a degenerative joint disease that affects mostly middle-aged and older adults, may cause the breakdown of joint cartilage and adjacent bone in the knees. Rheumatoid arthritis, which causes inflammation of the synovial membrane and results in excessive synovial fluid, can lead to pain and stiffness. Traumatic arthritis, arthritis due to injury, may cause damage to the cartilage of the knee.
Approval and launch of new knee replacement devices is expected to propel growth of the global knee replacement market during the forecast period. For instance, in August 2019, Fuse Medical Inc., an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced the launch of Sterizo Total Knee Replacement System, the latest addition to a comprehensive line of orthopedic product offerings. The Sterizo Total Knee System is a next-generation technology platform based on proven and accepted design principles in the orthopedic total knee arthroplasty marketplace. Its high flexion engineered, multi radius design delivers exceptional range of motion. The Sterizo Total Knee System offers full range of sizes as well as multiple stabilization options, including, Cruciate Retained, Ultra Congruent Anterior Stabilized, and Posterior Stabilized.
However, high cost of knee replacement surgery is expected to limit the market growth. For instance, the cost of various knee replacement surgeries such as total knee replacement surgery, partial knee replacement surgery, bilateral knee replacement surgery, minimal invasive knee replacement surgery, and revision knee replacement surgery are US$ 50,000, US$ 45,000, US$ 45,000, US$ 22,000, and US$ 20,000, respectively, in the U.S. Therefore, such expensive surgery procedures are expected to hinder the knee replacement market growth, as patients often opt out of the surgery and go for the alternatives such as physiotherapy, acupuncture, and other physical exercises.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.